Palisade Bio Has Received A Decision To Grant European Patent Number EP3209306 Titled "Stable Neural Stem Cells Comprising An Exogenous Polynucleotide Coding For A Growth Factor And Methods Of Use Thereof"
Portfolio Pulse from Happy Mohamed
Palisade Bio has been granted European Patent Number EP3209306, titled 'Stable Neural Stem Cells Comprising An Exogenous Polynucleotide Coding For A Growth Factor And Methods Of Use Thereof'.
May 24, 2023 | 3:19 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Palisade Bio has been granted a European patent for stable neural stem cells, potentially strengthening its intellectual property portfolio.
The granting of the European patent strengthens Palisade Bio's intellectual property portfolio in the field of neural stem cell technology. This could potentially lead to increased investor confidence and a positive impact on the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100